Information about the 2019 Novel Coronavirus
New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
Get the iPhone MyHealth app »
Get the Android MyHealth app »
The PARTNER Post Approval Study Part II
Trial ID or NCT#
Status
NOT RECRUITING
Purpose
The purpose of this post approval study is to determine the safety, effectiveness and learning curve of the SAPIEN™ THV with the Retroflex delivery system for Inoperable Patients and with the SAPIEN™ THV with Retroflex and Ascendra delivery systems for high risk operable patients with Severe Symptomatic Native Aortic Stenosis via all access sites.
Official Title
The PARTNER II Trial "Placement of AoRTic TraNscathetER" Valves Trial" (US) [PII B] for Inoperable Patients
Eligibility Criteria
Investigator(s)
Contact us to find out if this trial is right for you.
CONTACT
Spectrum Child Health
(650) 724-1175
View on ClinicalTrials.gov
About this Clinical Trial
The PARTNER Post Approval Study Part II
Your Message Will Go To
Spectrum Child Health650-724-1175